Thursday, October 11, 2012

Gene Therapy - Table of Contents alert Volume 19 Issue 10


TABLE OF CONTENTS

Volume 19, Issue 10 (October 2012)

In this issue
Original Articles
Short Communication

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement




Now accepting original research submissions!

Open access option - Competitive turnaround times - Internationally renowned Editorial Board

Serving the international community of researchers and physicians with in-depth coverage on all scientific and clinical aspects of bone health and disease.

Learn more about preparing your manuscript for submission.
 

Original Articles

Top

siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions

K Iwamura, T Kato, Y Miyahara, H Naota, J Mineno, H Ikeda and H Shiku

Gene Ther 2012 19: 959-966; advance online publication, November 24, 2011; 10.1038/gt.2011.185

Abstract | Full Text

S100A2 promoter-driven conditionally replicative adenovirus targets non-small-cell lung carcinoma

K Lee, S-T Yun, C-O Yun, B-Y Ahn and E-C Jo

Gene Ther 2012 19: 967-977; advance online publication, October 27, 2011; 10.1038/gt.2011.168

Abstract | Full Text

Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice

I Badea, C Virtanen, R E Verrall, A Rosenberg and M Foldvari

Gene Ther 2012 19: 978-987; advance online publication, November 10, 2011; 10.1038/gt.2011.159

Abstract | Full Text

Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4

J D Dias, O Hemminki, I Diaconu, M Hirvinen, A Bonetti, K Guse, S Escutenaire, A Kanerva, S Pesonen, A Löskog, V Cerullo and A Hemminki

Gene Ther 2012 19: 988-998; advance online publication, November 10, 2011; 10.1038/gt.2011.176

Abstract | Full Text

Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates

C-M Lai, M J Estcourt, R P Himbeck, S-Y Lee, I Yew-San Yeo, C Luu, B K Loh, M W Lee, A Barathi, J Villano, C-L Ang, R G van der Most, I J Constable, D Dismuke, R J Samulski, M A Degli-Esposti and E P Rakoczy

Gene Ther 2012 19: 999-1009; advance online publication, November 10, 2011; 10.1038/gt.2011.169

Abstract | Full Text

Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transfer

L Fjord-Larsen, P Kusk, D F Emerich, C Thanos, M Torp, B Bintz, J Tornøe, A H Johnsen and L U Wahlberg

Gene Ther 2012 19: 1010-1017; advance online publication, November 24, 2011; 10.1038/gt.2011.178

Abstract | Full Text

Physiological regulation of transgene expression by a lentiviral vector containing the A2UCOE linked to a myeloid promoter

C Brendel, U Müller-Kuller, S Schultze-Strasser, S Stein, L Chen-Wichmann, A Krattenmacher, H Kunkel, A Dillmann, M N Antoniou and M Grez

Gene Ther 2012 19: 1018-1029; advance online publication, November 10, 2011; 10.1038/gt.2011.167

Abstract | Full Text

Interferon-β efficiently inhibited endothelial progenitor cell-induced tumor angiogenesis

H-B Xiao, W-Y Zhou, X-F Chen, J Mei, Z-W Lv, F-B Ding, G-Q Li, H Zhong and C-R Bao

Gene Ther 2012 19: 1030-1034; advance online publication, November 10, 2011; 10.1038/gt.2011.171

Abstract | Full Text

Short Communication

Top

Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141+XCR1+ dendritic cells

K M Silk, J D Silk, N Ichiryu, T J Davies, K F Nolan, A J Leishman, L Carpenter, S M Watt, V Cerundolo and P J Fairchild

Gene Ther 2012 19: 1035-1040; advance online publication, November 10, 2011; 10.1038/gt.2011.177

Abstract | Full Text

Advertisement
2012 Nature/Institute for Genomic Medicine Symposium
November 4-5, 2012 - La Jolla, CA, USA

The following topics will be covered at the conference: Cancer Genomics, Gene & Cell Therapies, Complex Human Traits and Personalized Genomics for Implementation of Genetic Information.

Register today!
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: